STOCK TITAN

Brightspring Health Services Inc Financials

BTSGU
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Brightspring Health Services Inc (BTSGU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BTSGU FY2025

Scale-driven overhead leverage is finally turning a thin-margin business into one that produces real cash.

Gross margin fell from 14.8% in FY2023 to 11.8% in FY2025. Yet operating economics improved because SG&A absorbed less of each sales dollar, and that showed up in cash conversion: operating cash flow reached $490M versus net income of $189M. In FY2024, a small profit still came with negative free cash flow; by FY2025, free cash flow had swung to $395M, showing the business was funding itself after capital spending rather than only reporting accounting improvement.

The balance sheet is less burdened by borrowing than it was in FY2023, with debt-to-equity improving from 5.7x to 1.3x. As that leverage eased, interest expense fell to $157M, so more of the operating improvement reached net income instead of being absorbed below the operating line.

Liquidity looks acceptable on paper, with a current ratio of 1.6x, but cash was only $88.4M at FY2025 year-end. That means the company still depends heavily on working capital turnover—collecting receivables and moving inventory—rather than sitting on a large cash cushion, so day-to-day execution matters more than the cash balance alone suggests.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 42 / 100
Financial Profile 42/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Brightspring Health Services Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
26

Brightspring Health Services Inc has an operating margin of 2.3%, meaning the company retains $2 of operating profit per $100 of revenue. This below-average margin results in a low score of 26/100, suggesting thin profitability after operating expenses. This is up from 1.1% the prior year.

Growth
83

Brightspring Health Services Inc's revenue surged 28.2% year-over-year to $12.9B, reflecting rapid business expansion. This strong growth earns a score of 83/100.

Leverage
75

Brightspring Health Services Inc carries a low D/E ratio of 1.31, meaning only $1.31 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 75/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
27

Brightspring Health Services Inc's current ratio of 1.57 is below the typical benchmark, resulting in a score of 27/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
29

Brightspring Health Services Inc's free cash flow margin of 3.1% results in a low score of 29/100. Capital expenditures of $95.5M absorb a large share of operating cash flow.

Returns
11

Brightspring Health Services Inc generates a 10.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 11/100. This is up from 1.3% the prior year.

Piotroski F-Score Strong
7/9

Brightspring Health Services Inc passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.59x

For every $1 of reported earnings, Brightspring Health Services Inc generates $2.59 in operating cash flow ($490.2M OCF vs $189.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk
1.9x

Brightspring Health Services Inc earns $1.9 in operating income for every $1 of interest expense ($295.3M vs $157.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$12.9B
YoY+28.2%

Brightspring Health Services Inc generated $12.9B in revenue in fiscal year 2025. This represents an increase of 28.2% from the prior year.

EBITDA
$459.5M
YoY+47.1%

Brightspring Health Services Inc's EBITDA was $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 47.1% from the prior year.

Net Income
$189.1M
YoY+821.6%

Brightspring Health Services Inc reported $189.1M in net income in fiscal year 2025. This represents an increase of 821.6% from the prior year.

EPS (Diluted)
$0.87
YoY+1066.7%

Brightspring Health Services Inc earned $0.87 per diluted share (EPS) in fiscal year 2025. This represents an increase of 1066.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$394.7M
YoY+790.7%

Brightspring Health Services Inc generated $394.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 790.7% from the prior year.

Cash & Debt
$88.4M
YoY+45.0%

Brightspring Health Services Inc held $88.4M in cash against $2.5B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
192M
YoY+10.3%

Brightspring Health Services Inc had 192M shares outstanding in fiscal year 2025. This represents an increase of 10.3% from the prior year.

Margins & Returns

Gross Margin
11.8%
YoY-0.8pp

Brightspring Health Services Inc's gross margin was 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the prior year.

Operating Margin
2.3%
YoY+1.2pp

Brightspring Health Services Inc's operating margin was 2.3% in fiscal year 2025, reflecting core business profitability. This is up 1.2 percentage points from the prior year.

Net Margin
1.5%
YoY+1.3pp

Brightspring Health Services Inc's net profit margin was 1.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.3 percentage points from the prior year.

Return on Equity
10.1%
YoY+8.8pp

Brightspring Health Services Inc's ROE was 10.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 8.8 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$43.2M
YoY+6542.0%

Brightspring Health Services Inc spent $43.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 6542.0% from the prior year.

Capital Expenditures
$95.5M
YoY+18.0%

Brightspring Health Services Inc invested $95.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 18.0% from the prior year.

BTSGU Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $3.6B+1.8% $3.6B+6.5% $3.3B+5.9% $3.1B+9.4% $2.9B+54.9% $1.9B-36.1% $2.9B+6.5% $2.7B
Cost of Revenue N/A N/A N/A N/A N/A N/A $2.5B+6.7% $2.3B
Gross Profit $482.2M+16.9% $412.5M+5.2% $392.0M+4.6% $374.9M+10.8% $338.4M-0.1% $338.7M+4.8% $323.1M+3.5% $312.2M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $360.8M+18.5% $304.4M+0.1% $304.2M-6.8% $326.3M+13.4% $287.6M+1.6% $283.1M-3.7% $294.0M+7.5% $273.5M
Operating Income $121.4M+12.3% $108.1M+23.1% $87.8M+80.9% $48.6M-4.3% $50.7M-8.6% $55.5M+90.9% $29.1M-24.7% $38.7M
Interest Expense $38.6M+0.2% $38.5M+0.8% $38.2M-1.4% $38.8M-7.1% $41.8M-9.6% $46.2M-0.9% $46.6M+7.7% $43.3M
Income Tax $8.6M-57.3% $20.0M+65.2% $12.1M+879.0% $1.2M+615.8% -$240K-104.7% $5.1M-37.7% $8.2M+162.2% -$13.1M
Net Income $148.8M+97.0% $75.5M+35.3% $55.8M+97.9% $28.2M-4.5% $29.5M-45.9% $54.6M+763.2% -$8.2M-141.3% $19.9M
EPS (Diluted) $0.67 N/A $0.26+100.0% $0.13-7.1% $0.14 N/A $-0.04-140.0% $0.10

BTSGU Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $6.2B-3.1% $6.4B+6.0% $6.0B+1.8% $5.9B+1.7% $5.8B-1.3% $5.9B+2.4% $5.8B+3.2% $5.6B
Current Assets $2.7B-7.1% $2.9B+4.1% $2.8B+5.0% $2.6B+4.7% $2.5B+33.6% $1.9B+10.7% $1.7B+12.3% $1.5B
Cash & Equivalents $888.8M+905.8% $88.4M-37.0% $140.3M+100.3% $70.1M+33.9% $52.3M-14.1% $61.0M+69.4% $36.0M+43.7% $25.0M
Inventory $560.2M-31.3% $815.2M+27.5% $639.2M+2.2% $625.5M+17.2% $533.6M-16.2% $636.6M+33.1% $478.3M+27.8% $374.3M
Accounts Receivable $1.1B+12.5% $989.7M-2.3% $1.0B+4.1% $972.7M-0.3% $975.3M+8.0% $902.8M-12.0% $1.0B+4.2% $984.8M
Goodwill $2.5B-0.5% $2.5B+7.4% $2.4B0.0% $2.4B0.0% $2.4B+0.3% $2.4B-11.6% $2.7B+1.8% $2.6B
Total Liabilities $4.2B-6.7% $4.5B+7.1% $4.2B+0.7% $4.2B+1.0% $4.2B-2.8% $4.3B+2.6% $4.2B+4.2% $4.0B
Current Liabilities $1.5B-16.3% $1.8B+19.3% $1.5B+3.0% $1.5B+3.3% $1.5B+2.1% $1.4B+13.0% $1.3B+10.4% $1.1B
Long-Term Debt $2.4B-0.4% $2.5B-0.4% $2.5B-0.5% $2.5B-0.5% $2.5B-2.8% $2.6B-1.8% $2.6B+1.8% $2.6B
Total Equity $2.0B+5.6% $1.9B+3.1% $1.8B+4.3% $1.7B+3.3% $1.7B+2.4% $1.6B+2.0% $1.6B+1.0% $1.6B
Retained Earnings $14.1M+118.9% -$74.6M+31.2% -$108.6M+34.0% -$164.4M+14.6% -$192.6M+13.3% -$222.2M+5.2% -$234.4M-3.6% -$226.2M

BTSGU Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $122.9M-46.9% $231.6M+114.5% $107.9M+119.9% $49.1M-51.7% $101.6M+12.1% $90.6M+232.6% $27.2M+279.0% -$15.2M
Capital Expenditures $21.5M-42.8% $37.7M+139.0% $15.8M-35.5% $24.4M+38.5% $17.6M+15.2% $15.3M-23.6% $20.0M-15.6% $23.7M
Free Cash Flow $101.4M-47.7% $193.9M+110.4% $92.2M+273.9% $24.7M-70.6% $84.0M+11.5% $75.3M+945.4% $7.2M+118.5% -$39.0M
Investing Cash Flow $747.4M+419.6% -$233.9M-884.3% -$23.8M-2.2% -$23.2M+3.9% -$24.2M-53.3% -$15.8M+56.0% -$35.8M+37.9% -$57.7M
Financing Cash Flow -$70.0M-38.7% -$50.5M-285.3% -$13.1M-59.0% -$8.2M+90.4% -$86.0M-73.6% -$49.6M-353.8% $19.5M-51.1% $39.9M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $60.0M N/A N/A N/A N/A $0 $0-100.0% $325K

BTSGU Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 13.3%+1.7pp 11.6%-0.1pp 11.8%-0.2pp 11.9%+0.2pp 11.8%-6.5pp 18.2%+7.1pp 11.1%-0.3pp 11.4%
Operating Margin 3.4%+0.3pp 3.0%+0.4pp 2.6%+1.1pp 1.5%-0.2pp 1.8%-1.2pp 3.0%+2.0pp 1.0%-0.4pp 1.4%
Net Margin 4.1%+2.0pp 2.1%+0.5pp 1.7%+0.8pp 0.9%-0.1pp 1.0%-1.9pp 2.9%+3.2pp -0.3%-1.0pp 0.7%
Return on Equity 7.5%+3.5pp 4.0%+1.0pp 3.1%+1.5pp 1.6%-0.1pp 1.8%-1.6pp 3.3%+3.8pp -0.5%-1.8pp 1.3%
Return on Assets 2.4%+1.2pp 1.2%+0.3pp 0.9%+0.4pp 0.5%-0.0pp 0.5%-0.4pp 0.9%+1.1pp -0.1%-0.5pp 0.4%
Current Ratio 1.74+0.2 1.57-0.2 1.79+0.0 1.76+0.0 1.73+0.4 1.33-0.0 1.35+0.0 1.33
Debt-to-Equity 1.24-0.1 1.31-0.0 1.36-0.1 1.42-0.1 1.48-0.1 1.55-0.1 1.62+0.0 1.60
FCF Margin 2.8%-2.7pp 5.5%+2.7pp 2.8%+2.0pp 0.8%-2.1pp 2.9%-1.1pp 4.0%+3.8pp 0.3%+1.7pp -1.4%

Frequently Asked Questions

Brightspring Health Services Inc (BTSGU) reported $12.9B in total revenue for fiscal year 2025. This represents a 28.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Brightspring Health Services Inc (BTSGU) revenue grew by 28.2% year-over-year, from $10.1B to $12.9B in fiscal year 2025.

Yes, Brightspring Health Services Inc (BTSGU) reported a net income of $189.1M in fiscal year 2025, with a net profit margin of 1.5%.

Brightspring Health Services Inc (BTSGU) reported diluted earnings per share of $0.87 for fiscal year 2025. This represents a 1066.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Brightspring Health Services Inc (BTSGU) had EBITDA of $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Brightspring Health Services Inc (BTSGU) had $88.4M in cash and equivalents against $2.5B in long-term debt.

Brightspring Health Services Inc (BTSGU) had a gross margin of 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Brightspring Health Services Inc (BTSGU) had an operating margin of 2.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Brightspring Health Services Inc (BTSGU) had a net profit margin of 1.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Brightspring Health Services Inc (BTSGU) has a return on equity of 10.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Brightspring Health Services Inc (BTSGU) generated $394.7M in free cash flow during fiscal year 2025. This represents a 790.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Brightspring Health Services Inc (BTSGU) generated $490.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Brightspring Health Services Inc (BTSGU) had $6.4B in total assets as of fiscal year 2025, including both current and long-term assets.

Brightspring Health Services Inc (BTSGU) invested $95.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Brightspring Health Services Inc (BTSGU) spent $43.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Brightspring Health Services Inc (BTSGU) had 192M shares outstanding as of fiscal year 2025.

Brightspring Health Services Inc (BTSGU) had a current ratio of 1.57 as of fiscal year 2025, which is generally considered healthy.

Brightspring Health Services Inc (BTSGU) had a debt-to-equity ratio of 1.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Brightspring Health Services Inc (BTSGU) had a return on assets of 2.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Brightspring Health Services Inc (BTSGU) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Brightspring Health Services Inc (BTSGU) has an earnings quality ratio of 2.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Brightspring Health Services Inc (BTSGU) has an interest coverage ratio of 1.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Brightspring Health Services Inc (BTSGU) scores 42 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top